Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA5bzhpSFhtdFhQbGV4WVg2YnRKZnV2X2FPMmxyVXJpbF96aC1oYk9LNEFVZjZoLUtVZzJZaE5pWm9sNmFjalRVVFZjRHFYOEczY1U5UTc2ZjY1RnVNVjc4?oc=5" target="_blank">Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors | Signal Transduction and Targeted Therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay
Bank of America fined $1.2 billion over money-laundering violations
LIVE: Dan toch 1-1! Club laat zich na penalty Tresoldi te makkelijk vangen, Lautaro zorgt voor gelijkmaker
Nach 6:0 in der Liga: Demichelis erwartet anderes Kaliber
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5WWDROUGRhbXlNTmZ0Qk94cVdkVGNpRXFSU0thQ1kxS0xzU3FMSEpwdHpsM0tkVVdVb2l3QmNuQXBCTE9LSk83VlBFbEZUZkcxNjlmTDV1V3c5d0NDbzVv?oc=5" target="_blank">Rapid CAR screening and circRNA-driven CAR-NK cells for persistent shed-resistant immunotherapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQR0U2a0RWcXY3TzhjblFBVlI1bXVmYnFUZFFkN2JiWVh2T0Z5dVVmUHgySC1DSzhOLVlPS1BlNmc0VXItQktkZS1lVTFpR1dxU005MjRIM1JERmRFOWV0M1BkT2lDNkRjSXhtVjFGUWl3N0NjRy1SQTdjRE5raE53eEtPT0swNjVLX1NJbDlrTU4?oc=5" target="_blank">Single-cell RNA-Seq reveals the potential risk of anti-mesothelin CAR T Cell therapy toxicity to different organs in humans</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9rWTlLYWtuaHVEd0pidlBDTVdSYTFRR292dXVKQ05aYmZjemNSV1FmQVFVTURtNGlnNFE4b3VpTzlraXBoYUpGR3FaVHV0dHJnSmhVemNOeTFGbnNidW9n?oc=5" target="_blank">IL-21 promotes the anti-tumor effect of anti-CD47 chimeric antigen receptor macrophages in ovarian cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5ZNEhMWUxvTW12N0tQREJHY01BS2pXdHNUQklGMGxYSHdQMzNSRUM0YXZpTzQySjd2S0NwTnRoX3lLRlBZaEJlMnY0b0pGcG9zcGNrbWQzaTVfTWtYbm1R?oc=5" target="_blank">Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma</a>&nbsp;&nbsp;<font color="#6f6f6f">Science | AAAS</font>
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE1IZExDVG8wZ0FkTDMzVTZ2akpNZVp2bGZwTmtxekhJbDZNT0w4ZkFJRk5vN3E4ZUhScFBWem5KRUlsaFlRNWE0dzdJckZ4Z0ZQc0VwcDVtejJGdGF3SnRXQkFYOVZvV0VzdnBKbjlWMVlHLUoyYnc?oc=5" target="_blank">Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies</a>&nbsp;&nbsp;<font color="#6f6f6f">Wiley & Sons</font>
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPZFlNWkdvbGVrQ1hmV1c3VnFWVnoxbjFucVRpcmF5VjJOZVlSLU1ZWUVINk5iYUhsMWxmUGFqZVdDeDViT1gwRkVnRENvU3JzZTNjVXFfc0RleVoxUHZXQVVubkRBVmRvTTZyM0FHc09rSGNGWGpZUEtYZThyRy16N2VZRVFJVkEzdmh2cm1TUFFIdGxtOWtmR0JFSmppQQ?oc=5" target="_blank">CAR TEAM Cells Show Promise in Multiple Preclinical Models of Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">CGTLive®</font>
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE9pSHRfUVNkMHlQbUhybUhldmZpLUpvMERuVWRGWV9tNkx3cWtwV19hWnJscmtnTURQZ2FoQ1pQMGs3enRSS2tDQkRvQ1pUSF8tZ2NXcEpUNTZCTlhH?oc=5" target="_blank">Dual-targeted ping-pong CAR T cells: Leveraging peripheral expansion to improve solid tumor immunotherapy</a>&nbsp;&nbsp;<font color="#6f6f6f">PNAS</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBKbzAxRzFMZmE1Sl9pQzJMMzRRQ0RMdFZJUFA5VTJmNnJZLXRMQlM2ZHdUZDZXVEdsaWQ1WWwtYVhscXZNU0pSb190RC1XWmFRTWdidG9zS0ZTNGJ1Z1JZ?oc=5" target="_blank">The TCR in CAR T cell therapy: use it or lose it?</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQaVF3RzFLNUtYcHItOXJqa1dnb0dNTUZGaUZRVGd0cVlRYXQ2bnBydzF3ZXRnWllZd1NSYXBpMVRHQUJJZVRnUzV6elliaFdpQWotTWVSYkxxYUx2aGN1RFJXVEtVQjZpMG8xN29hWDRBNmR5dnFUQkpNZnNBVlUxMDhwd1paZVFlNGlqZ2RqT09Rdw?oc=5" target="_blank">CAR-NK cell for gynecological cancers: immune microenvironment remodeling and immunotherapeutic strategies</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE9JMDhjNUlfLUQweEJsNTVYRUY5bFBxVl9UR19ZX1FkS3NuT3pEUEpPT19RTDBORXM0TkhtejY1NHBZaV8yWi05R2s2S1U1SW5Vd3BkdERtR2h1VExhazBqS0FNUGVfQ2dfQUN4dmtLRFg?oc=5" target="_blank">Novel FRET-based Immunological Synapse Biosensor for the Prediction of Chimeric Antigen Receptor-T Cell Function</a>&nbsp;&nbsp;<font color="#6f6f6f">Wiley Online Library</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOdkk0Vi1rbGZNc1hjdFFKU3c5dTVMR1FTbU8tSHl1eDZYSWtvTTBydmhxeUZaWmJDcW5TOHgzV3FUWFA5RW9rc1lfUDllMS1HN2JnM3dPZFZoc1pXMlJncmVmQUJSU01URVZUVVI0MkJLcE5UZ20tc2d5c3lVaDBaT1lLYzQ4NXItcVh6YVEyVkx1QQ?oc=5" target="_blank">A structural, genetic and clinical comparison of CAR-T cells and CAR-NK cells: companions or competitors?</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5IdV9yX2xfM0VUMlpOa0JlczJlVmcyUmNFODctLWhSZVhKbjVxM3VscGhRbEk0VHZ3dmNNQXBVUExyMEM3dDhVaU9CRnpDTFZvRUY5YmgzRGFXSjdCY2NR?oc=5" target="_blank">Optimization of THP-1-CAR monocytes utilizing CD32a signaling phagocytosis for antigen-specific T cell activation</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5OYTk1Sm1YR0I1aUxVd1EzbFFxQTBNUUU4STFTLU9PdlJkR1lWTTFqOW9NeTNwaVZCZ2pGeG5sZjdGaGN1eEhldmdKSFZieVN2azBENU5BblJHTnUyZXpJ?oc=5" target="_blank">Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB5OVRITkR2aXRNdVRpR2pQZnBodWo2OWdISHBwcnM4TmFZbzlCcmJvY2QzMTFtVmRUZmk5UXdSYnNDZ3BKYUdLbEFUdjhjZ2NGRVA0WWZFRV9xeG5jUnNv?oc=5" target="_blank">Breakthrough of solid tumor treatment: CAR-NK immunotherapy - Cell Death Discovery</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5BRkVuWVhqejZOaEFlT2YxUTVINEJZMmFyY1VYQWNRejFuV2FLQ094d0tLWEdBcHRmdTdpRFRzVWl5V25MQzJQTURyVDltamdYZ0NxYWhRVGw1b016UjNF?oc=5" target="_blank">CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9DVGxOWW1GNm5YT1ZMSTBReWZaeHczLV9fUS1XdUdlMUt1R2F6Y0JDNWpiWkUxRzl4UUFYVExVcGplLWJHdk1RQUt0cFNUa21tWThhdzg0U3JMQk1TandJ?oc=5" target="_blank">A cell-based phenotypic library selection and screening approach for the de novo discovery of novel functional chimeric antigen receptors</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE93TDNUV2RFTXdTOW5GSk1MR1NHQXBJcWRwYTl2UWV6QXlQZ3pPMmtSSEdpaDdyZC1nN2cxeW4xQnFEYUJfM25pMWczUm1GRGQ5dnJlUmstN3BNUHRkYWc4?oc=5" target="_blank">The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB4aFpRMS1mSW9VYzJRUlJCSWE5NTVENFl1V2NsSEo5U2xmalFHR2kwZjNWRnFST3FKQm92NGFpZFphRkdfUU9oTEFTRXFrZGR5OTFDVmgtUGZUSW94RlF3?oc=5" target="_blank">Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5BUTdIYzJqTEhqREo4RDUtZklZbmx6U0VfQWZ6SnVub0tuaVdBbEdIT3JDRmJEam5IeE5BdUg2RmhDUllWVFNySXREbHhIQkEwOTByU3M4QW11VWYzVzlR?oc=5" target="_blank">HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivo</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBOc2RjSG14cVdkQThxMFdxT0ZWa1lQR0htVzdodGxPZ3d3TWxFdlNxR091TGhfNFFQRGttSTdRVWlJT2pKbEp4dVdJZFNpTXBpbkpXUXpvUEU1UHdzV2xCLTZSRGg1eGpYVEw0?oc=5" target="_blank">Harnessing chimeric antigen receptor macrophages against solid tumors - Wang - 2025 - Cancer Communications</a>&nbsp;&nbsp;<font color="#6f6f6f">Wiley Online Library</font>
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPazRyVkt0WnU1aERpUzlwU2RmY3RlckpMMGtMNkJsbVNXNjB4NTFoWXV5ZWpiaXVxMVdoMENwUEJUMlk5VURPZlI2SS0xc2lPUVI1U21jV2prbzdSOWNFbU5CSWFCY1VDMEgxYVRJRlgtLWVtNGpLc2dYRTBQWlZrQ3g2eF9UcTRiSUlJY1Fn?oc=5" target="_blank">Anti-ROR1 CAR-T cells: Architecture and performance</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5KSS1fZmFwNVhIMlJ2WGJMY1phMl9WRHNjQUg5bWZ3WnA0aWZabXhlZUxWam5vTnJZb2ZpTVNtcWh3cktKMC16WW9BdUtXSXdTdWhQdzNWOHNGN3B4RElF?oc=5" target="_blank">HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5mX3BLakpjbFMtNTd5bWczNy15LU94Y18yeXJKZjRBTXBwY1dpSDBsandDV2I0U1JDMzBhVnltOUFqN2xoY3pfNFk5UlZCYUNTMGpQN2diTmY5aHk3UG5J?oc=5" target="_blank">CAR-engineered lymphocyte persistence is governed by a FAS ligand–FAS autoregulatory circuit</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE14TGR2ZGN4R2ZxS1VnWE1JUkJsUTFzWHpIV3EwQi1WT3M0ZFczUXFUVWFkYVcwMG5QN0RQeTNEYzBrSVNybjJCVHAyMmNLWlg2UHFFRl82Q2VVa2tGNjFJ?oc=5" target="_blank">Lung metastasis and recurrence is mitigated by CAR macrophages, in-situ-generated from mRNA delivered by small extracellular vesicles</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNMXEtZ2RDb0VaeUlSdTNEdkUwOGthMUpIMkI0bFdFQzJlNncyX0FsQ2NFalpqLUo2TE9nY0tfR3hKbW1ONm1hWnNES0hVUlNXVnNyLVZuWDhTNzdwS0JobTZobVdLX0RBR3c0NUxITDJ2TzNlVEEzRi02NzQwb1lEUnFIb0xCdS1GV0pDNGcyV2pQdw?oc=5" target="_blank">Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapies</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTFBjMVZ5dUVYSzdhb1JuVmVOQ2RvNllreUdxY2c3dUxLX2dhb2RTWGJCWmM1QlJjd2pYb3VGZ0VwMWtnVHAzNGlxX1d1TjNkODBjREVZdGc2R1BXNlU1Z0E?oc=5" target="_blank">Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5tSnRfT2ZvTko3OVBjLTBUb3hDUDhRUEtLQzZ0SExCdGtzajNlQVI4dzZpa0lORmlka1FldEpPWDhqTTl4bzlSWGxfOHUySGJFYklaZjg5TTJyU1cxa1Zz?oc=5" target="_blank">Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQOVFrNFdCLU9tZi1uWDBubkpoaDdfcWdQTjZsWGlpMmh3ZFBpVnZsaVEtYk5qajBYeXF3LUhFQi1FZkF0X01wN1RkNlVISXdaTlI4MUtuNUY0MVJyNWNnLVhSQkZOV2RYT2N4XzMwb3Z3UVdOWFB0dGw0VFB2VU1wNnl6djhiZl9wbmlZ?oc=5" target="_blank">Insights Into the Role of Mesothelin as a Diagnostic and Therapeutic Target in Ovarian Carcinoma</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9sNVZrZEVoZWxhMHdNdlJpbFROUFdEVVo5UDBTZmswa3RSc1g4bk9wZU0tNlJlNkZka0hrYUJKbERNVW10bHROYi10OVRMTGo5T1p5NjNIX2JXZ0pFRFFF?oc=5" target="_blank">T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>